UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-22033
MFS SERIES TRUST XIV
(Exact name of registrant as specified in charter)
111 Huntington Avenue, Boston, Massachusetts 02199 (Address of principal executive offices) (Zip code)
Christopher R. Bohane
Massachusetts Financial Services Company
111Huntington Avenue Boston, Massachusetts 02199
(Name and address of agents for service)
Registrant's telephone number, including area code: (617) 954-5000
Date of fiscal year end: August 31
Date of reporting period: February 28, 2023
ITEM 1. REPORTS TO STOCKHOLDERS.
Item 1(a):
Money Market Portfolio
Money Market Portfolio
1 | |
2 | |
3 | |
4 | |
6 | |
7 | |
8 | |
9 | |
10 | |
15 | |
15 | |
15 | |
15 |
back cover |
A-1+ | 31.7% |
A-1 | 68.3% |
Other Assets Less Liabilities (o) | (0.0)% |
0 - 7 days | 60.7% |
8 - 29 days | 29.1% |
30 - 59 days | 7.9% |
60 - 89 days | 2.3% |
Other Assets Less Liabilities (o) | (0.0)% |
(a) | Ratings are assigned to portfolio securities utilizing ratings from Moody’s, Fitch, and Standard & Poor’s rating agencies and applying the following hierarchy: If all three agencies provide a rating, the middle rating (after dropping the highest and lowest ratings) is assigned; if two of the three agencies rate a security, the lower of the two is assigned. Ratings are shown in the S&P scale. All ratings are subject to change. The fund did not hold unrated securities. The fund is not rated by these agencies. |
(o) | Less than 0.1%. |
(u) | For purposes of this presentation, accrued interest, where applicable, is included. |
September 1, 2022 through February 28, 2023
Annualized Expense Ratio | Beginning Account Value 9/01/22 | Ending Account Value 2/28/23 | Expenses Paid During Period (p) 9/01/22-2/28/23 | |
Actual | 0.01% | $1,000.00 | $1,017.77 | $0.05 |
Hypothetical (h) | 0.01% | $1,000.00 | $1,024.74 | $0.05 |
(h) | 5% fund return per year before expenses. |
(p) | “Expenses Paid During Period” are equal to the fund’s annualized expense ratio, as shown above, multiplied by the average account value over the period, multiplied by 181/365 (to reflect the one-half year period). |
Issuer | Shares/Par | Value ($) | ||
Commercial Paper (y) – 22.2% | ||||
Automotive – 3.1% | ||||
Toyota Motor Credit Corp., 4.53%, due 3/10/2023 | $125,000,000 | $124,842,604 | ||
Toyota Motor Credit Corp., 4.67%, due 4/10/2023 | 75,000,000 | 74,606,742 | ||
$199,449,346 | ||||
Computer Software - Systems – 3.5% | ||||
Apple, Inc., 4.46%, due 3/06/2023 (t) | $225,000,000 | $224,830,276 | ||
Conglomerates – 0.8% | ||||
Siemens Capital Corp., 4.52%, due 3/02/2023 (t) | $54,000,000 | $53,986,632 | ||
Food & Beverages – 0.8% | ||||
Coca-Cola Co., 4.74%, due 5/09/2023 (t) | $50,000,000 | $49,549,180 | ||
Major Banks – 4.4% | ||||
ANZ Bank, 4.68%, due 4/11/2023 (t) | $185,056,000 | $184,063,946 | ||
Toronto-Dominion Bank, 4.58%, due 3/30/2023 (t) | 100,000,000 | 99,619,667 | ||
$283,683,613 | ||||
Other Banks & Diversified Financials – 3.8% | ||||
Mizuho Bank Ltd., 4.73%, due 4/24/2023 (t) | $100,000,000 | $99,292,486 | ||
National Bank of Canada, 4.68%, due 4/03/2023 (t) | 150,000,000 | 149,348,191 | ||
$248,640,677 | ||||
Pharmaceuticals – 4.9% | ||||
Johnson & Johnson, 4.48%, due 3/13/2023 (t) | $150,000,000 | $149,757,767 | ||
Johnson & Johnson, 4.78%, due 5/15/2023 (t) | 100,000,000 | 99,029,100 | ||
Novartis AG, 4.53%, due 3/03/2023 (t) | 20,000,000 | 19,992,568 | ||
Novartis AG, 4.55%, due 3/20/2023 (t) | 46,000,000 | 45,884,438 | ||
$314,663,873 | ||||
Retailers – 0.9% | ||||
Walmart, Inc., 4.51%, due 3/03/2023 (t) | $60,000,000 | $59,977,640 | ||
Total Commercial Paper (Identified Cost, $1,434,913,534) | $1,434,781,237 | |||
U.S. Government Agencies and Equivalents (y) – 73.7% | ||||
Federal Home Loan Bank, 4.3%, due 3/01/2023 | $712,808,000 | $712,808,000 | ||
Federal Home Loan Bank, 4.4%, due 3/01/2023 | 1,655,500,000 | 1,655,500,000 | ||
Federal Home Loan Bank, 4.51%, due 3/08/2023 | 500,000,000 | 499,559,420 | ||
U.S. Treasury Bill, 4.42%, due 3/02/2023 | 175,000,000 | 174,978,671 | ||
U.S. Treasury Bill, 4.5%, due 3/07/2023 | 253,000,000 | 252,813,306 | ||
U.S. Treasury Bill, 4.5%, due 3/09/2023 | 328,000,000 | 327,673,686 |
Issuer | Shares/Par | Value ($) | ||
U.S. Government Agencies and Equivalents (y) – continued | ||||
U.S. Treasury Bill, 4.49%, due 3/14/2023 | $218,000,000 | $217,648,176 | ||
U.S. Treasury Bill, 4.48%, due 3/16/2023 | 205,000,000 | 204,618,167 | ||
U.S. Treasury Bill, 4.52%, due 3/21/2023 | 221,500,000 | 220,948,711 | ||
U.S. Treasury Bill, 4.48%, due 3/23/2023 | 241,000,000 | 240,365,859 | ||
U.S. Treasury Bill, 4.55%, due 3/28/2023 | 249,000,000 | 248,157,524 | ||
Total U.S. Government Agencies and Equivalents (Identified Cost, $4,755,044,970) | $4,755,071,520 | |||
Repurchase Agreements – 4.1% | ||||
Bank of America Corp. Repurchase Agreement, 4.51%, dated 2/28/2023, due 3/01/2023, total to be received $117,771,550 (secured by U.S. Treasury and/or U.S. Government Agency Securities valued at $121,285,102) | $117,757,000 | $117,757,000 | ||
Goldman Sachs Repurchase Agreement, 4.49%, dated 2/28/2023, due 3/01/2023, total to be received $50,006,151 (secured by U.S. Treasury and/or U.S. Government Agency Securities valued at $51,000,008) | 50,000,000 | 50,000,000 | ||
JPMorgan Chase & Co. Repurchase Agreement, 4.51%, dated 2/28/2023, due 3/01/2023, total to be received $94,011,615 (secured by U.S. Treasury and/or U.S. Government Agency Securities valued at $95,892,022) | 94,000,000 | 94,000,000 | ||
Total Repurchase Agreements, at Cost and Value | $261,757,000 | |||
Other Assets, Less Liabilities – (0.0)% | (103,659) | |||
Net Assets – 100.0% | $6,451,506,098 |
(t) | Security exempt from registration with the U.S. Securities and Exchange Commission under Section 4(2) of the Securities Act of 1933. |
(y) | The rate shown represents an annualized yield at time of purchase. |
Assets | |
Investments in unaffiliated issuers, at value (identified cost, $6,451,715,504) | $6,451,609,757 |
Cash | 55,413,291 |
Receivables for | |
Fund shares sold | 136,540,809 |
Interest | 32,765 |
Other assets | 17,696 |
Total assets | $6,643,614,318 |
Liabilities | |
Payables for | |
Fund shares reacquired | $191,953,636 |
Payable to affiliates | |
Administrative services fee | 96 |
Shareholder servicing costs | 226 |
Accrued expenses and other liabilities | 154,262 |
Total liabilities | $192,108,220 |
Net assets | $6,451,506,098 |
Net assets consist of | |
Paid-in capital | $6,451,716,347 |
Total distributable earnings (loss) | (210,249) |
Net assets | $6,451,506,098 |
Shares of beneficial interest outstanding | 6,451,194,754 |
Net asset value per share (net assets of $6,451,506,098 / 6,451,194,754 shares of beneficial interest outstanding) | $1.0000 |
Net investment income (loss) | |
Income | |
Interest | $113,387,892 |
Other | 1,133 |
Total investment income | $113,389,025 |
Expenses | |
Shareholder servicing costs | $511 |
Administrative services fee | 8,679 |
Insurance expense | 15,016 |
Custodian fee | 181,299 |
Shareholder communications | 1,097 |
Audit and tax fees | 19,686 |
Legal fees | 18,189 |
Commitment fee | 19,571 |
Miscellaneous | 16,740 |
Total expenses | $280,788 |
Fees paid indirectly | (31,337) |
Net expenses | $249,451 |
Net investment income (loss) | $113,139,574 |
Change in unrealized appreciation or depreciation | |
Unaffiliated issuers | $211,613 |
Net realized and unrealized gain (loss) | $211,613 |
Change in net assets from operations | $113,351,187 |
Six months ended | Year ended | |
2/28/23 (unaudited) | 8/31/22 | |
Change in net assets | ||
From operations | ||
Net investment income (loss) | $113,139,574 | $38,231,867 |
Net realized gain (loss) | — | (104,502) |
Net unrealized gain (loss) | 211,613 | (276,215) |
Change in net assets from operations | $113,351,187 | $37,851,150 |
Total distributions to shareholders | $(113,139,574) | $(38,231,867) |
Change in net assets from fund share transactions | $(1,484,748,705) | $(874,065,209) |
Total change in net assets | $(1,484,537,092) | $(874,445,926) |
Net assets | ||
At beginning of period | 7,936,043,190 | 8,810,489,116 |
At end of period | $6,451,506,098 | $7,936,043,190 |
Six months ended | Year ended | |||||
2/28/23 (unaudited) | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 | 8/31/18 | |
Net asset value, beginning of period | $1.0000 | $1.0000 | $1.0000 | $1.0000 | $1.0000 | $1.0000 |
Income (loss) from investment operations | ||||||
Net investment income (loss) (d) | $0.0174 | $0.0043 | $0.0006 | $0.0108 | $0.0234 | $0.0153 |
Net realized and unrealized gain (loss) | 0.0002 | 0.0005 | 0.0000(w) | 0.0006 | 0.0001 | 0.0002 |
Total from investment operations | $0.0176 | $0.0048 | $0.0006 | $0.0114 | $0.0235 | $0.0155 |
Less distributions declared to shareholders | ||||||
From net investment income | $(0.0176) | $(0.0048) | $(0.0006) | $(0.0114) | $(0.0235) | $(0.0155) |
Net asset value, end of period | $1.0000 | $1.0000 | $1.0000 | $1.0000 | $1.0000 | $1.0000 |
Total return (%) (r) | 1.78(n) | 0.48 | 0.06 | 1.15 | 2.37 | 1.56 |
Ratios (%) (to average net assets) and Supplemental data: | ||||||
Expenses (f) | 0.01(a) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Net investment income (loss) | 3.51(a) | 0.43 | 0.06 | 1.08 | 2.34 | 1.53 |
Net assets at end of period (000 omitted) | $6,451,506 | $7,936,043 | $8,810,489 | $8,571,713 | $6,090,451 | $5,548,949 |
(a) | Annualized. |
(d) | Per share data is based on average shares outstanding. |
(f) | Ratios do not reflect reductions from fees paid indirectly, if applicable. See Note 2 in the Notes to Financial Statements for additional information. |
(n) | Not annualized. |
(r) | Certain expenses have been reduced without which performance would have been lower. |
(w) | Per share amount was less than $0.0001. |
Financial Instruments | Level 1 | Level 2 | Level 3 | Total |
Short-Term Securities | $— | $6,451,609,757 | $— | $6,451,609,757 |
Year ended 8/31/22 | |
Ordinary income (including any short-term capital gains) | $38,231,867 |
As of 2/28/23 | |
Cost of investments | $6,451,715,504 |
Gross appreciation | 45,730 |
Gross depreciation | (151,477) |
Net unrealized appreciation (depreciation) | $(105,747) |
As of 8/31/22 | |
Capital loss carryforwards | (104,502) |
Net unrealized appreciation (depreciation) | (317,360) |
Short-Term | $(104,502) |
Six months ended 2/28/23 | Year ended 8/31/22 | ||||
Shares | Amount | Shares | Amount | ||
Shares sold | 28,394,469,079 | $28,396,120,493 | 64,097,175,224 | $64,096,859,685 | |
Shares issued to shareholders in reinvestment of distributions | 113,129,864 | 113,139,557 | 38,233,039 | 38,231,867 | |
Shares reacquired | (29,992,362,885) | (29,994,008,755) | (65,009,657,932) | (65,009,156,761) | |
Net change | (1,484,763,942) | $(1,484,748,705) | (874,249,669) | $(874,065,209) |
Item 1(b):
Not applicable.
ITEM 2. CODE OF ETHICS.
During the period covered by this report, the Registrant has not amended any provision in its Code of Ethics (the "Code") that relates to an element of the Code's definition enumerated in paragraph (b) of Item 2 of this Form N-CSR. During the period covered by this report, the Registrant did not grant a waiver, including an implicit waiver, from any provision of the Code.
ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.
Not applicable for semi-annual reports.
ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
Not applicable for semi-annual reports.
ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.
Not applicable to the Registrant.
ITEM 6. INVESTMENTS
A schedule of investments for each series covered by this Form N-CSR is included as part of the report to shareholders of such series under Item 1(a) of this Form N-CSR.
ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable to the Registrant.
ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable to the Registrant.
ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.
Not applicable to the Registrant.
ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
There were no material changes to the procedures by which shareholders may send recommendations to the Board for nominees to the Registrant's Board since the Registrant last provided disclosure as to such procedures in response to the requirements of Item 407 (c)(2)(iv) of Regulation S-K or this Item.
ITEM 11. CONTROLS AND PROCEDURES.
(a)Based upon their evaluation of the effectiveness of the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the "Act")) as conducted within 90 days of the filing date of this report on Form N-CSR, the Registrant's principal financial officer and principal executive officer have concluded that those disclosure controls and procedures provide reasonable assurance that the material information required to be disclosed by the Registrant on this report is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms.
(b)There were no changes in the Registrant's internal controls over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the period covered by the report that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.
ITEM 12. DISCLOSURE OF SECURITIES LENDING ACTIVITIES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable to the Registrant.
ITEM 13. EXHIBITS.
(a)(1) Any code of ethics, or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy the Item 2 requirements through filing of an exhibit: Not applicable.
(2)A separate certification for each principal executive officer and principal financial officer of the registrant as required by Rule 30a-2(a) under the Act (17 CFR 270.30a-2): Attached hereto as EX-99.302CERT.
(3)Any written solicitation to purchase securities under Rule 23c-1 under the Act (17 CFR 270.23c-1) sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons. Not applicable.
(4)Change in the registrant's independent public accountant. Not applicable.
(b)If the report is filed under Section 13(a) or 15(d) of the Exchange Act, provide the certifications required by Rule 30a-2(b) under the Act (17 CFR 270.30a-2(b)), Rule 13a-14(b) or Rule 15d-14(b) under the Exchange Act (17 CFR 240.13a-14(b) or 240.15d-14(b)) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) as an exhibit. A certification furnished pursuant to this paragraph will not be deemed "filed" for the purposes of Section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference. Attached hereto as EX-99.906CERT.
Notice
A copy of the Declaration of Trust, as amended, of the Registrant is on file with the Secretary of State of The Commonwealth of Massachusetts and notice is hereby given that this instrument is executed on behalf of the Registrant by an officer of the Registrant as an officer and not individually and the obligations of or arising out of this instrument are not binding upon any of the Trustees or shareholders individually, but are binding only upon the assets and property of the respective constituent series of the Registrant.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) MFS SERIES TRUST XIV
By (Signature and Title)*
/S/ DAVID L. DILORENZO
David L. DiLorenzo, President
Date: April 14, 2023
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title)*
/S/ DAVID L. DILORENZO
David L. DiLorenzo, President (Principal Executive Officer)
Date: April 14, 2023
By (Signature and Title)*
/S/ JAMES O. YOST
James O. Yost, Treasurer (Principal Financial Officer and Accounting Officer) Date: April 14, 2023
* Print name and title of each signing officer under his or her signature.